These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 6343655)

  • 1. Regionalized self-care hemodialysis. A solution to the increasing cost.
    Wauters JP; Hunziker A; Brunner HR
    JAMA; 1983 Jul; 250(1):59-62. PubMed ID: 6343655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of end-stage chronic renal failure in Switzerland].
    Spertini F; Wauters JP
    Schweiz Med Wochenschr; 1985 May; 115(21):722-7. PubMed ID: 3892661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health economic evaluations: the special case of end-stage renal disease treatment.
    Winkelmayer WC; Weinstein MC; Mittleman MA; Glynn RJ; Pliskin JS
    Med Decis Making; 2002; 22(5):417-30. PubMed ID: 12365484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Self dialysis: a new method of treatment for end-stage renal disease].
    Fournier G; Gaillard JL; Matha N; Man NK
    Nephrologie; 1984; 5(3):115-8. PubMed ID: 6493429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal function substitutes. Technical and logistic orientation of the treatment].
    Legrain M; Rottembourg J
    Ann Med Interne (Paris); 1982; 133(8):611-24. PubMed ID: 6763488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost of dialysis in France].
    Benain JP; Faller B; Briat C; Jacquelinet C; Brami M; Aoustin M; Dubois JP; Rieu P; Behaghel C; Duru G
    Nephrol Ther; 2007 Jun; 3(3):96-106. PubMed ID: 17540311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access.
    Lee H; Manns B; Taub K; Ghali WA; Dean S; Johnson D; Donaldson C
    Am J Kidney Dis; 2002 Sep; 40(3):611-22. PubMed ID: 12200814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
    Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost effectiveness analysis of the treatment of end stage renal failure.
    Croxson BE; Ashton T
    N Z Med J; 1990 Apr; 103(888):171-4. PubMed ID: 2109846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing the paradigm from contraction of peritoneal dialysis programs to increasing prevalent peritoneal dialysis numbers.
    Cross J; Davenport A
    Adv Perit Dial; 2013; 29():50-4. PubMed ID: 24344492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Substitutes for renal function. Technical trends and logistics of treatment].
    Legrain M; Rottembourg J
    C R Seances Soc Biol Fil; 1981; 175(5):669-93. PubMed ID: 6456794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic consequences of an increased number of patients on outgoing dialysis.
    Olsen J; Bonnevie B; Palmhøj-Nielsen C; Povlsen JV
    Scand J Urol Nephrol; 2010 Dec; 44(6):452-8. PubMed ID: 20632841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-care dialysis fits in with new economic challenges for providers.
    Usewicz MC
    Nephrol News Issues; 2011 Aug; 25(9):34-5. PubMed ID: 21905529
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal replacement therapy. 11. The cost of treating chronic renal failure.
    Pincherle G
    Nurs Times; 1982 Jul 7-13; 78(27):1153-4. PubMed ID: 6920717
    [No Abstract]   [Full Text] [Related]  

  • 18. Critical appraisal of continuous ambulatory peritoneal dialysis.
    Friedman EA
    Annu Rev Med; 1984; 35():233-48. PubMed ID: 6372656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of Dialysis Therapy by Modality in Manitoba.
    Beaudry A; Ferguson TW; Rigatto C; Tangri N; Dumanski S; Komenda P
    Clin J Am Soc Nephrol; 2018 Aug; 13(8):1197-1203. PubMed ID: 30021819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting treatment costs and life expectancy for end-stage renal disease.
    Stange PV; Sumner AT
    N Engl J Med; 1978 Feb; 298(7):372-8. PubMed ID: 340947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.